References
- Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA (2011). Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. Am J Roentgenol, 196, 218-24. https://doi.org/10.2214/AJR.10.4550
- King V, Brooks JD, Bernstein JL, et al (2011). Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology, 260, 50-60. https://doi.org/10.1148/radiol.11102156
- King V, Goldfarb SB, Brooks JD, et al (2012a). Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology, 264, 670-8. https://doi.org/10.1148/radiol.12112669
- King V, Gu Y, Kaplan JB, et al (2012b). Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol, 22, 2641-7. https://doi.org/10.1007/s00330-012-2553-8
- King V, Kaplan J, Pike MC, et al (2012c). Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J, 18, 527-34. https://doi.org/10.1111/tbj.12002
- Li J, Dershaw DD, Lee CH, Joo S, Morris EA (2010). Breast MRI after conservation therapy: usual findings in routine follow-up examinations. Am J Roentgenol, 195, 799-807. https://doi.org/10.2214/AJR.10.4305
- Morris EA (2010). Diagnostic breast MR imaging: current status and future directions. Magn Reson Imaging Clin N Am, 18, 57-74. https://doi.org/10.1016/j.mric.2009.09.005
- Mousa NA, Eiada R, Crystal P, Nayot D, Casper RF (2012). The effect of acute aromatase inhibition on breast parenchymal enhancement in magnetic resonance imaging: a prospective pilot clinical trial. Menopause, 19, 420-5. https://doi.org/10.1097/gme.0b013e31823772a8
Cited by
- Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response vol.26, pp.6, 2016, https://doi.org/10.1007/s00330-015-4011-x
- The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy vol.39, pp.3, 2016, https://doi.org/10.1097/COC.0000000000000290
- Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy vol.284, pp.3, 2017, https://doi.org/10.1148/radiol.2017162123
- Evaluation of background parenchymal enhancement on breast MRI: a systematic review vol.90, pp.1070, 2017, https://doi.org/10.1259/bjr.20160542
- Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk pp.1527-7755, 2019, https://doi.org/10.1200/JCO.18.00378